Details for New Drug Application (NDA): 017395
✉ Email this page to a colleague
NDA 017395 describes INTROPIN, which is a drug marketed by Hospira and is included in one NDA. Additional details are available on the INTROPIN profile page.
The generic ingredient in INTROPIN is dopamine hydrochloride. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
The generic ingredient in INTROPIN is dopamine hydrochloride. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
Summary for 017395
| Tradename: | INTROPIN |
| Applicant: | Hospira |
| Ingredient: | dopamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017395
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 40MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 80MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 160MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
